Progestin and estrogen content of oral contraceptives (birth control pills) chart.
This meta-analysis evaluated the effects of different therapeutic approaches on the live birth rate and maternal outcomes of pregnant women with MPNs.
A retrospective cohort study explored outcomes for pregnant women with HL who received antenatal chemotherapy compared with a match cohort of nonpregnant women.
Evidence suggests that women with myeloproliferative neoplasms have a higher risk of maternal and fetal complications. In this data analysis, researchers evaluated outcomes for pregnant women with essential thrombocythemia, polycythemia, or myelofibrosis and their infants.